Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.

Sakti ChakrabartiTyler J ZemlaDaniel H AhnFang-Shu OuBriant FruthMitesh J BoradMindy L HartgersJaclynn WesslingRachel L WalkesSteven R AlbertsRobert R McWilliamsMinetta C LiuLori M DurginTanios S Bekaii-SaabAmit Mahipal

Published in: The oncologist (2019)

FTD/TPI demonstrated promising antitumor activity, with acceptable toxicity, in heavily pretreated patients with advanced BTC.

Keyphrases

metastatic colorectal cancer
oxidative stress
open label
clinical trial
oxide nanoparticles